Clinical Trials Directory

Trials / Completed

CompletedNCT01627977

Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy

A Descriptive Study to Evaluate the Effectiveness of the Dye Compound of the Combination of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to test the efficacy of the combination of dye Lutein, Zeaxanthin and brilliant blue to stain the internal limiting membrane as well as the epiretinal membranes during the Vitrectomy surgery.

Detailed description

Twenty five patients with epiretinal membrane, macular hole or proliferative diabetic retinopathy and indication of vitrectomy surgery will be selected to participate in this study.

Conditions

Interventions

TypeNameDescription
OTHERDye of Lutein, Zeaxanthin and Brilliant Bluedye composed of Lutein, Zeaxanthin and Brilliant Blue will be used during the vitrectomy surgery to dye the membranes

Timeline

Start date
2012-10-01
Primary completion
2014-01-01
Completion
2014-03-01
First posted
2012-06-26
Last updated
2016-03-16

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01627977. Inclusion in this directory is not an endorsement.